Literature DB >> 977683

Quantitative determination of low levels of daunomycin and daunomycinol in plasma by high-performance liquid chromatography.

R Hulhoven, J P Desager.   

Abstract

A high-performance liquid chromatographic method for the measurement of daunomycin and its main metabolite, daunomycinol, at low concentrations in plasma is described. Quantitative determinations were obtained by the use of adriamycin, another cystostatic anthracycline antibiotic, as an internal standard. The separations were carried out on a 5-mum silica microsphere column with a quaternary solvent mixture as eluent. The components in the eluted peaks were detected by visible absorption at 490 nm and there were no interfering peaks. The advantages of the method are specificity, sensitivity, minimal pre-analysis sample work-up and small sample size. The method is sensitive for plasma levels of daunomycin and daunomycinol above 10 ng/ml. Experimental animal data are presented to illustrate the application of the method.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977683     DOI: 10.1016/s0021-9673(00)93832-9

Source DB:  PubMed          Journal:  J Chromatogr


  11 in total

1.  Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice.

Authors:  R Baurain; D Deprez-De Campeneere; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Sensitive absorption-based wave-mixing detector for anthracycline drugs separated by capillary electrophoresis.

Authors:  Sandrine Berniolles; Hongjing Kan; William G Tong
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2010-06-23       Impact factor: 4.098

3.  A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.

Authors:  W Bolanowska; T Gessner; H Preisler
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography.

Authors:  D E Brenner; S Galloway; J Cooper; R Noone; K R Hande
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Human pharmacokinetics of the daunorubicin-DNA complex. An alternative view of the lysosomotropic theory.

Authors:  R Hulhoven; G Sokal; C Harvengt
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 6.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

7.  Uptake and metabolism of daunorubicin by human leukemia cells.

Authors:  M W DeGregorio; C J Carrera; J C Klock; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

8.  Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma.

Authors:  A Ferrant; R Hulhoven; A Bosly; G Cornu; J L Michaux; G Sokal
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  CE-LIF method for the separation of anthracyclines: application to protein binding analysis in plasma using ultrafiltration.

Authors:  Gillian Whitaker; Amy Lillquist; Stephanie A Pasas; Robert O'Connor; Fiona Regan; Craig E Lunte; Malcolm R Smyth
Journal:  J Sep Sci       Date:  2008-06       Impact factor: 3.645

10.  A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.

Authors:  N Erb; R Erttmann; G Landbeck
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.